616
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Present and future cholera vaccines

&
Pages 751-752 | Published online: 09 Jan 2014

References

  • Ryan ET, Calderwood SB, Qadri F. Live attenuated oral cholera vaccines. Expert Rev Vaccines5(4), 483–494 (2006).
  • Clemens JD, Sack DA, Harris J et al. Field trial of cholera vaccines in Bangladesh. Lancet2, 124–127 (1986).
  • Van Loon FP, Clemens JD, Chakraborty J et al. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine14, 162–166 (1996).
  • Sanchez Jl, Vasquez B, Begue RE et al. Protective efficacy of oral whole-cell/ recombinant-B-subunit cholera vaccines in Peruvian military recruits. Lancet344, 1273–1276 (1994).
  • Taylor DN, Cardenas V, Sanchez JL et al. Two-year study of the protective efficacy of the oral whole cell puls recombinant B subunit cholera vaccine in Peru. J. Infect. Dis.181, 1667–1673 (2000).
  • Clemens JD, Sack DA, Ivanoff B. Misleading negative findings in a field trial of killed oral cholera vaccine in Peru. J. Infect. Dis.185, 1306–1308 (2001).
  • Lucas MES, Deen JL, von Seilein L et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N. Eng. J. Med.352, 757–767 (2005).
  • Clemens JD, Sack DA, Harris JR et al. Cross-protection by B subunit whole cell cholera vaccine against diarrhea associated with heatlabile toxin-producing enterotoxigenic Escherichia coli: result of a large-scale field trial. J. Infect. Dis.158, 1285–1289 (1988).
  • Peltola H, Siitonen A, Kyronseppa H et al. Prevention of travelers’ diarrhea by oral B-subunit/whole-cell cholera vaccine. Lancet338, 1285–1289 (1991).
  • Scerpella EG, Sanchez JL, Mathewson JJ 3rd et al. Safety, immunogenicity, and protective efficacy of the whole-cell/ recombinant B subunit (WC/rBS) oral cholera vaccine against travelers’ diarrhea. J. Travel Med.2, 22–27 (1995).
  • Leyten EM, Soonawala D, Schultsz C et al. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers’ diarrhoea in a randomised, double-blind, placebo-controlled study. Vaccine23, 5120–5126 (2005).
  • Harris J. Vaccination campaign against cholera in Mayotte. Aventis Pasteur, internal memo. May 14 (2001).
  • Legros D, Paquet C, Perea W et al. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull. World Health Organ.77, 837–842 (1999).
  • Dorlencourt F, Legros D, Paquet C, Neira M, Ivanoff B, Le Saout E. Effectiveness of mass vaccination with WC/rBS cholera vaccine during an epidemic in Adjumani district, Uganda. Bull. World Health Organ.77, 949–950 (1999).

Website

  • EMEA. EPAR, Scientific discussion (2004) www.emea.eu.int/humandocs/EPAR/dukoral/dukoral.htm

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.